The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Lindis Biotech competitive analysis

Loading summary...

Latest oppositions filed by Lindis Biotech

Explore patent oppositions filed by Lindis Biotech against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2637670
Prevention Of Adverse Effects Caused By Cd3 Specific Binding DomainsAMGENDec 7, 2017

Latest patents of Lindis Biotech opposed by its competitors

Explore Lindis Biotech's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3177645
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer10

Latest PTAB cases involving Lindis Biotech

Discover the latest PTAB cases involving Lindis Biotech, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Lindis Biotech with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LINDIS BIOTECH110 - -
ABBVIE109 - 1
AMGEN8138811
AMGEN RESEARCH MUNICH - 30 - -